0001771941-19-000001.txt : 20190404 0001771941-19-000001.hdr.sgml : 20190404 20190404133156 ACCESSION NUMBER: 0001771941-19-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20190404 DATE AS OF CHANGE: 20190404 EFFECTIVENESS DATE: 20190404 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Perfuse Therapeutics, Inc. CENTRAL INDEX KEY: 0001771941 IRS NUMBER: 833240662 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-336458 FILM NUMBER: 19731725 BUSINESS ADDRESS: STREET 1: 1700 OWENS STREET STREET 2: SUITE 540 CITY: SAN FRANCISCO STATE: CA ZIP: 94158 BUSINESS PHONE: 1-415-272-1083 MAIL ADDRESS: STREET 1: 1700 OWENS STREET STREET 2: SUITE 540 CITY: SAN FRANCISCO STATE: CA ZIP: 94158 D 1 primary_doc.xml X0708 D LIVE 0001771941 Perfuse Therapeutics, Inc. 1700 OWENS STREET SUITE 540 SAN FRANCISCO CA CALIFORNIA 94158 1-415-272-1083 DELAWARE None None Corporation true 2018 Sevgi Gurkan 1700 Owens Street, Suite 540 San Francisco CA CALIFORNIA 94158 Executive Officer Director Promoter Chau Khuong 1700 Owens Street, Suite 540 San Francisco CA CALIFORNIA 94158 Director Christy Shaffer 1700 Owens Street, Suite 540 San Francisco CA CALIFORNIA 94158 Director Other Technology Decline to Disclose 06b false 2019-03-21 false true false 0 4000000 2000000 2000000 false 6 0 0 0 false Perfuse Therapeutics, Inc. /S/ SEVGI GURKAN Sevgi Gurkan Chief Executive Officer 2019-04-04